About Qing Liu-Michael
Qing Liu-Michael is a director at AcuraStem.
Qing Liu-Michael first appears on SEC filings in 2018.
Experience
This experience comes from Qing Liu-Michael's profile and from SEC filings. For roles taken from filings, the years are when the filings name Qing Liu-Michael in the role, so the role may have started earlier or lasted longer.
QL
QLM Consulting LLC Current
Founder and Principal Consultant
2024 – Present
CC
City of Hope Medical Center Current
Director
2021 – Present
AcuraStem Inc Current
Co-Founder and Board member
2016 – Present · Pasadena, CA
Develops treatments for people with ALS, frontotemporal dementia and other neurodegenerative diseases.
HI
Harvard Stem Cell Institute
Associate Director for Strategic Alliances
2008 – 2010
SA
sanofi-aventis
Senior Research Scientist
2006 – 2008
CU
Curis
Program Manager, Discovery Stem Cell Group
2005 – 2006
Key Colleagues at Startups
The people Qing Liu-Michael works with at each company, as listed on that company's latest Form D.
AcuraStem Inc · Form D, Jun 22, 2026
Samuel Alworth
Co-founder and CEO, director
Paul August
Co-founder and director
Marcel van der Brug
Chief Scientific Officer
Justin Ichida
Co-founder and director